the Study, conducted at Gothenburg university in sweden shows that patients with very severe covid-19 is sometimes a significant symptom in that the brain is not functioning as it should.
However, this does not affect only the most severely ill, but is already at a moderate risk of infection, among patients who were admitted to the hospital, but did not have respiratory care, it was possible to detect the damage.
the study was based on two different resources, one of them is increased when the patient had a moderate-covid-19. The cursor is known as GFAp, is a gliafibrillärt acid protein, and is found normally in the brain stjärnceller. However, the leakage, if there is an injury or damage to the over-activation.
this is The second biomarker, which was examined, was in the NfL, neurofilament light. It is normally found in the nervcellsutskotten, and to stabilize them. However, in the NfL, leaks out into the blood if they are injured. The concentration increase of most of the people in the study who have been treated in a respirator. The study shows that the increase in the leakage of blood if injured.
”Can you give a direct brain injury”
in the NfL, the concentration increased in the majority of patients who needed to be cared for on a ventilator, and it was clear that the ökningens-size and could be associated with the severity of the disease.
" the Increase in, above all, in the NfL, over a period of time at a higher level than we have seen in our previous studies, in the context of intensive care, which suggests that the covid-19 can actually provide a direct brain injury. If it is a virus or immune cells that are for this are currently unclear and more research is needed, " says Henrik Zetterberg, professor of neurochemistry, whose team of researchers at the Sahlgrenska academy conducted the measurements in a press release.
a Total of 47 patients with mild, moderate, and severe covid-19 and had to leave blood samples collected during the care process. The results have then been compared with a healthy control group.
the Study, published in the journal of Neurology.
a New drug to help against obesity: ”Very well,”